{"name":"Austrian Forum Against Cancer","slug":"austrian-forum-against-cancer","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Dexamethasone, Bortezomib, Doxorubicin","genericName":"Dexamethasone, Bortezomib, Doxorubicin","slug":"dexamethasone-bortezomib-doxorubicin","indication":"Other","status":"phase_2"}]}],"pipeline":[{"name":"Dexamethasone, Bortezomib, Doxorubicin","genericName":"Dexamethasone, Bortezomib, Doxorubicin","slug":"dexamethasone-bortezomib-doxorubicin","phase":"phase_2","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiakFVX3lxTE1HR3l2THktLXNjQ3JhWlc4eUZmckpMQjNHTkU2eXJLY0RWZ2I4aHoySHhuUkdWMm1nbXRqQUtHYjhiNFVPMVNMQ0NFN3VzbXVNTnVKZHdoSkxQQkdBa3Zyd3dlR1NZZk1YekE?oc=5","date":"2025-10-24","type":"pipeline","source":"Wiley Online Library","summary":"Parameters Associated With Renal Recovery and Survival in Myeloma Patients With Acute Renal Failure to Cast Nephropathy - Wiley Online Library","headline":"Parameters Associated With Renal Recovery and Survival in Myeloma Patients With Acute Renal Failure to Cast Nephropathy","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMidEFVX3lxTE5IU3BTdlUzbWlELWFiSXFMeGpPZlNJUGN1eE9IMzA4U0NJVkh3XzFra3FBbDNOa2RZamhjX0xUbmw4VnJJWU5kWGlNNWhZMkpOdUQzdkR6QUYwRC1uZHhTSXVNbVg3WHptVGJlWEtDYU5qSkhI?oc=5","date":"2025-02-21","type":"deal","source":"pharmaphorum","summary":"Poolbeg slumps as Hookipa merger is called off - pharmaphorum","headline":"Poolbeg slumps as Hookipa merger is called off","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMioAFBVV95cUxPdUJud0piUjRCQnpVV1VCSy1zSklZSmNFU0hSalRRaTVqb01QTjFzQ1AzRlB2elJHRDdnLWJRejV6czNad0FiVGpyWExRRmo5M1RqRXE2cGVBNUVyXzVudmk4MlpjRHdESnh1TjVDOE84LV9Cc0NXOTdjbS15a2xhRjI4QTd5SE81VVg2bXNEeXdmRjltMXNGR0V4R1ZoYm1U?oc=5","date":"2024-01-23","type":"patent","source":"Generics and Biosimilars Initiative","summary":"Biocon to commercialize biosimilars in 31 European countries - Generics and Biosimilars Initiative","headline":"Biocon to commercialize biosimilars in 31 European countries","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_2":1},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}